期刊文献+

保留幽门胰十二指肠切除术在胰腺癌手术中的应用研究 被引量:2

Pylorus preserving pancreaticoduodenectomy for pancreatic cancer operation in application
下载PDF
导出
摘要 目的探讨保留幽门胰十二指肠切除术在胰腺癌手术中的应用意义及临床价值。方法回顾性分析50例胰腺癌手术患者,行标准胰十二指肠切除术患者25例为对照组,行保留幽门胰十二指肠切除术25例患者为观察组,对照两组患者手术时间、输血量、最早恢复正常饮食功能时间、总并发症发生率,随访1年后生存率。结果两组患者手术时间、输血量、最早恢复正常饮食功能时间比较(t=4.33、4.55、4.42,P<0.05);两组患者总并发症发生率(χ2=4.45,P<0.05);两组患者1年后生存率(χ2=2.45,P>0.05)。结论保留幽门胰十二指肠切除术较标准十二指肠切除术手术时间短、输血量少、最早恢复正常饮食功能时间快、总并发症发生率少,临床效果可靠,两组患者一年后生存率具有显著性差异。 Objective To investigate the pylorus-preserving pancreatoduodenectomy in pancreatic cancer operation significance in the application and clinical value. Methods A retrospective analysis of 50 casesofpancreatic cancer patients with operation, line standard pancreaticoduodenectomy in patients 25 cases as control group, line of pylorus-preserving pancreaticoduodenectomy for the observation group 25 cases, control group two patients with operation time, amount of blood transfusion, the early resumption of normal diet function time, total complication rate, follow-up after 1 years survival rate. Results In two groups of patients with operation time, amount of blood transfusion, the early resumption of normal diet function time (t=4.33,4.55,4.42, P〈 0.05),two patients total complication rate (χ2=4.45, P〈 0.05),two patients after 1 year survival rate (χ2=2.45, P〉 0.05). Conclusion Pylorus preserving pancreaticoduodenectomy with standard pancreaticoduodenectomy shorter operation time, less blood transfusion, the earliest to resume a normal diet function time, total complication rate less reliable, clinical effects, two groups of patients after one year survival rate has significant difference.
出处 《中国实用医药》 2012年第19期51-52,共2页 China Practical Medicine
关键词 保留幽门胰十二指肠切除术 胰腺癌 Pancreatoduodenectomy; Pancreatic cancer
  • 相关文献

参考文献8

二级参考文献22

  • 1Jemal A, Siegel R, Ward E, et al. Cancer Statistics 2008. CA Cancer J Clin, 2008,58:71-96. 被引量:1
  • 2Lochan R, Daly AK, Reeves HL, et al, Genetic susceptibility in pancreatic ductal adenoearcinoma. Bri J Surg, 2008,95 : 22-32. 被引量:1
  • 3Hassan MM, Bondy ML, Wolff RA, et al. Risk Factors for Pancreatic Cancer: Case-Control Study. Am J Gastroenterol, 2007, 102: 2696-2707. 被引量:1
  • 4Katz MH, Hwang R, Fleming JB, et al. Tumor-node-metastasis staging of pancreatic adenocarcinoma. CA Cancer J Clin, 2008,58:111-125. 被引量:1
  • 5Raut CP, Tseng JF, Sun CC, et al. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg, 2007,246 : 52- 60. 被引量:1
  • 6Westgaard A, Tafjord S, Farstad IN, et al, Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor. BMC Cancer, 2008,14:5. 被引量:1
  • 7Samra JS, Gananadha S, Hugh TJ. Surgical management of carcinoma of the head of pancreas: extended iymphadenectomy of modified en bloc resection? ANZ J Surg, 2008, 78:228-236. 被引量:1
  • 8Farnell MB, Aranha GV, Nimura Y, et al. The role of extended lymphadenectomy for adenocareinoma of the head ofthe pancreas: strength of the evidence. J Gastrointest Surg, 2008, 12:651-656. 被引量:1
  • 9Adsay NV, Conlon KC, Zee SY, et al. Intraductal papillary mucinous neoplasms of the pancreas: an analysis of in situ and invasive carcinomas in 28 patients[J]. Cancer, 2002, 94:62-77. 被引量:1
  • 10Burris HA,Moore MJ,Andersen J, et al . Improvements in survival and clinical benefit with gemcitabine as first line therapy for patients with advanced pancreas cancer : a randomized trial[J]. J Clin Oncol, 1997,15:2403-2413. 被引量:1

共引文献128

同被引文献12

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部